Potent antitumor activity of oncolytic adenovirus-mediated SOCS1 for hepatocellular carcinoma. (Q39399622)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318090%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Potent antitumor activity of oncolytic adenovirus-mediated SOCS1 for hepatocellular carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318090%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318090%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

L Liu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318090%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

W Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318090%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

X Wei

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318090%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Q Cui

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318090%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

G Wang

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318090%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

X Hu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318090%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

C Qian

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318090%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

9 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318090%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318090%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318090%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318090%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

84-92

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22318090%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/gt.2012.4

22 January 2020

exact match

0 references

cites work

STATs in cancer inflammation and immunity: a leading role for STAT3

1 reference

Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment.

21 January 2018

1 reference

STAT3 as a central regulator of tumor metastases

21 January 2018

1 reference

Signal transducer and activator of transcription 3 (Stat3) in epithelial carcinogenesis

21 January 2018

1 reference

The STATs of cancer--new molecular targets come of age

21 January 2018

1 reference

21 January 2018

1 reference

Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity

21 January 2018

1 reference

Development of a STAT3 reporter prostate cancer cell line for high throughput screening of STAT3 activators and inhibitors

21 January 2018

1 reference

Uniquely modified RNA oligonucleotides targeting STAT3 suppress melanoma growth both in vitro and in vivo

21 January 2018

1 reference

17-hydroxy-jolkinolide B inhibits signal transducers and activators of transcription 3 signaling by covalently cross-linking Janus kinases and induces apoptosis of human cancer cells.

21 January 2018

1 reference

Suppressors of cytokine signaling: Relevance to gastrointestinal function and disease

21 January 2018

1 reference

SOCS1 induced by NDRG2 expression negatively regulates STAT3 activation in breast cancer cells.

21 January 2018

1 reference

CpG island hypermethylation of SOCS-1 gene is inversely associated with HBV infection in hepatocellular carcinoma.

21 January 2018

1 reference

Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma

21 January 2018

1 reference

Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.

21 January 2018

1 reference

A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells.

21 January 2018

1 reference

Treatment of cancer with a novel dual-targeted conditionally replicative adenovirus armed with mda-7/IL-24 gene

21 January 2018

1 reference

Potent antitumor activity of oncolytic adenovirus expressing mda-7/IL-24 for colorectal cancer.

21 January 2018

1 reference

An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice.

21 January 2018

1 reference

The RB and p53 pathways in cancer

21 January 2018

1 reference

The oncolytic adenovirus targeting to TERT and RB pathway induced specific and potent anti-tumor efficacy in vitro and in vivo for hepatocellular carcinoma

21 January 2018

1 reference

Mode of transgene expression after fusion to early or late viral genes of a conditionally replicating adenovirus via an optimized internal ribosome entry site in vitro and in vivo

21 January 2018

1 reference

Replication-dependent transgene expression from a conditionally replicating adenovirus via alternative splicing to a heterologous splice-acceptor site.

21 January 2018

1 reference

Transduction peptides: from technology to physiology

21 January 2018

1 reference

A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment

21 January 2018

1 reference

New aspects of diagnosis and therapy of hepatocellular carcinoma.

21 January 2018

1 reference

Therapy of cancer by cytokines mediated by gene therapy approach

21 January 2018

1 reference

Potent antitumor activity in experimental hepatocellular carcinoma by adenovirus-mediated coexpression of TRAIL and shRNA against COX-2.

21 January 2018

1 reference

Positron emission tomography imaging of adenoviral-mediated transgene expression in liver cancer patients

21 January 2018

1 reference

Phase I trial of intratumoral injection of an adenovirus encoding interleukin-12 for advanced digestive tumors.

21 January 2018

1 reference

Transfer of suppressor of cytokine signaling 3 by an oncolytic adenovirus induces potential antitumor activities in hepatocellular carcinoma

21 January 2018

1 reference

Oncolytic viral therapies - the clinical experience

21 January 2018

1 reference

Oncolytic adenoviruses - selective retargeting to tumor cells

21 January 2018

1 reference

Stat proteins and oncogenesis

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

STAT proteins: novel molecular targets for cancer drug discovery

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Hypermethylation associated with inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human hepatoblastomas

1 reference